Adagene (ADAG) vs Canton Strategic (CNTN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Adagene (ADAG) has outperformed Canton Strategic (CNTN) over the past year, gaining 41.2% versus a loss of 25.2%. Adagene is the larger company by market cap ($186.7 million vs $165.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADAG | CNTN |
|---|---|---|
| Share price | $2.78 | $2.08 |
| Market cap | $186.66M | $165.74M |
| 1-day change | -1.07% | -7.96% |
| YTD return | +48.68% | -25.41% |
| 1-year return | +41.21% | -25.17% |
| 5-year return | -75.98% | — |
| EPS (TTM) | $-0.38 | $-0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.85 | $6.89 |
| 52-week low | $1.30 | $1.75 |
| Distance from 52-week high | -42.68% | -69.81% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +256.47% | — |
| Average volume | 245.22K | 751.76K |
| Shares outstanding | 67.14M | 79.68M |
| Employees | 128 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ADAG has outperformed CNTN by 66.4 percentage points over the past year.
About Adagene
ADAG stock →Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 128 employees
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
ADAG vs CNTN FAQ
Which is bigger, Adagene or Canton Strategic?
Adagene (ADAG) is larger, with a market capitalization of $186.66M compared with $165.74M for Canton Strategic (CNTN).
Which stock has performed better over the past year, ADAG or CNTN?
ADAG returned +41.21% over the past 12 months, compared with -25.17% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Are Adagene and Canton Strategic in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.